We report the development of palladium(0)‐catalyzed syn‐selective 1,2‐carboboration and ‐silylation reactions of alkenes containing cleavable directing groups. With B2pin2 or PhMe2Si‐Bpin as nucleophiles and aryl/alkenyl triflates as electrophiles, a broad range of mono‐, di‐, tri‐ and tetrasubstituted alkenes are compatible in these transformations. We further describe a directed dearomative 1,2‐carboboration of electron‐rich heteroarenes by employing this approach. Through use of a removable chiral directing group, we demonstrate the viability of achieving stereoinduction in Heck‐type alkene 1,2‐difunctionalization. This work introduces new avenues to access highly functionalized boronates and silanes with precise regio‐ and stereocontrol.
Abstract2,3-Dihydrobenzofurans and indolines are common substructures in medicines and natural products. Herein, we describe a method that enables direct access to these core structures from non-conjugated alkenyl amides and ortho-iodoanilines/phenols. Under palladium(II) catalysis this [3 + 2] heteroannulation proceeds in an anti-selective fashion and tolerates a wide variety of functional groups. N-Acetyl, -tosyl, and -alkyl substituted ortho-iodoanilines, as well as free –NH2 variants, are all effective. Preliminary results with carbon-based coupling partners also demonstrate the viability of forming indane core structures using this approach. Experimental and computational studies on reactions with phenols support a mechanism involving turnover-limiting, endergonic directed oxypalladation, followed by intramolecular oxidative addition and reductive elimination.
The
control of chemo-, regio-, diastereo-, and enantioselectivity
is a central theme in organic synthesis. The capability to obtain
the full set of stereoisomers of a molecule would significantly enhance
the efficiency for the synthesis of natural product analogues and
creation of chiral compound libraries for drug discovery. Despite
the tremendous progress achieved in the field of asymmetric synthesis
in the past decades, the precise control of both relative and absolute
configurations in catalyst-controlled reactions that create multiple
stereocenters remains a significant synthetic challenge. We report
here the development of a catalyst-controlled hydroboration with hitherto
unattainable selectivity. The Rh-catalyzed hydroboration of α,
β-unsaturated carbonyl compounds with pinacolborane proceeds
with high levels of regio-, diastereo-, and enantioselectivities to
provide a hydroboration product with two vicinal stereocenters. Through
the appropriate choice of substrate geometry (E or Z) and ligand enantiomer (S or R), all the possible diastereoisomers are readily accessible.
The boron-containing products underwent many stereospecific transformations,
thus providing a strategy for collective stereodivergent synthesis
of diverse valuable chiral building blocks.
2,3-Dihydrobenzofurans and indolines are common substructures in medicines and natural products. Herein, we describe a method that enables direct access to these core structures from non-conjugated alkenyl amides and <i>ortho</i>-iodoanilines/phenols. Under palladium(II) catalysis this [3+2] heteroannulation proceeds in an <i>anti</i>-selective fashion and tolerates a wide variety of functional groups. <i>N</i>-Acetyl, -tosyl, and -alkyl substituted <i>ortho</i>-iodoanilines, as well as free –NH<sub>2</sub> variants, are all effective. Preliminary results with carbon-based coupling partners also demonstrate the viability of forming indane core structures using this approach. Experimental and computational data with phenols support a mechanism involving turnover-limiting, endergonic directed oxypalladation, followed by intramolecular oxidative addition and reductive elimination.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.